Anixa Biosciences (ANIX) Net Equity Issued and Repurchased (2010 - 2026)
Anixa Biosciences (ANIX) recorded Net Equity Issued and Repurchased of $1.94 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 0.8% from $1.92 million a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
On a TTM basis, Anixa Biosciences' Net Equity Issued and Repurchased came in at $4.33 million as of Jul 31, 2026, up 128.5% year-over-year; for FY2025 (ended Oct 31, 2025), it was $2.38 million, down 19.5% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -23.8% (FY2020 to FY2025).
- Across earlier fiscal years, Net Equity Issued and Repurchased came in at $2.96 million in FY2024 (+737.1%), $353,000 in FY2023 (-19.6%), $439,000 in FY2022 (-97.8%) and $20.29 million in FY2021 (+119.0%).
- The fiscal Q3 2026 figure is the highest quarterly Net Equity Issued and Repurchased since fiscal Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Anixa Biosciences | 101.52 Mn | 87.66 Mn | - | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.94 Mn |
| Oct 31, 2025 | 457,000.00 |
| Jul 31, 2025 | 1.93 Mn |
| Apr 30, 2025 | 18,000.00 |
| Jan 31, 2025 | -17,000.00 |
| Oct 31, 2024 | 112,000.00 |
| Jul 31, 2024 | 149,000.00 |
| Apr 30, 2024 | 897,000.00 |
| Jan 31, 2024 | 2.26 Mn |
| Oct 31, 2023 | 279,000.00 |
| Jul 31, 2023 | 3,000.00 |
| Apr 30, 2023 | 81,000.00 |
| Jan 31, 2023 | 3,000.00 |
| Oct 31, 2022 | -384,000.00 |
| Jul 31, 2022 | 829,000.00 |
| Oct 31, 2021 | -2.41 Mn |
| Apr 30, 2021 | 27.91 Mn |
| Jan 31, 2021 | 6.06 Mn |
| Oct 31, 2020 | 1.09 Mn |
| Jul 31, 2020 | 5.01 Mn |
API Access
Anixa Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();